Related Experiment Video

Updated: Jul 18, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Influenza vaccination: the paediatric perspective

Jose Ramet1, C Weil-Olivier, W Sedlak

  • 1Universitair Ziekenhuis Antwerpen, Department of Paediatrics, UZA & ZNA Koningin Paola Kinderziekenhuis, Antwerp, Belgium. jose.ramet@zna.be

Vaccine
|November 15, 2006
PubMed

Insights

Influenza poses significant risks for young children, who are prone to complications and spread the virus. More European data is needed on the disease burden and vaccination benefits to inform public health strategies.

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Vaccinology

Background:

  • Young children are highly susceptible to influenza complications.
  • Children are significant vectors for community-wide influenza transmission.
  • Limited European data exists on pediatric influenza burden and vaccination impact.

Purpose of the Study:

  • To highlight the need for European data on pediatric influenza.
  • To emphasize the importance of vaccination for children.
  • To guide the development of European guidelines and educational strategies.

Main Methods:

  • Review of existing European data (paucity noted).
  • Analysis of disease burden in young children.
  • Evaluation of health benefits and cost-effectiveness of vaccination.

Main Results:

  • Significant disease burden of influenza in European children is likely.
  • Lack of data hinders awareness among policymakers and healthcare professionals.
  • US and elderly data offer potential models for European studies.

Conclusions:

  • Urgent need for robust European studies on pediatric influenza.
  • Evidence generation is crucial for informed vaccination policies and public awareness.
  • Leveraging international experience can inform European strategies.

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...